Profitability Ratios
| Ratio |
Value |
| GP Margin |
51.7% |
| EBIT Margin |
-29.2% |
| EBITDA Margin |
-19.9% |
| Operating Margin |
4.2% |
| Pretax Margin |
-34.5% |
| Cont. Ops Margin |
-31.6% |
| Net Margin |
-31.6% |
| Bottom Line Margin |
-31.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.54 |
| Quick Ratio |
1.46 |
| Solvency Ratio |
-0.143 |
| Cash Ratio |
0.52 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.00 |
| Forward PEG |
-0.00 |
| Price/Book |
0.91 |
| Price/Sales |
0.58 |
| Price/FCF |
-30.70 |
| Price/Op Cash Flow |
18.92 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5645 |
| Debt/Equity |
1.9485 |
| Debt/Capital |
0.6608 |
| Long-Term Debt/Capital |
0.6237 |
| Financial Leverage |
3.45 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
3.79 |
| Operating Cash Flow Ratio |
0.110 |
| Operating Cash Flow/Sales |
3.1% |
| Free Cash Flow/Operating Cash Flow |
-61.6% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-1.31 |
| Interest Coverage |
0.7920 |
| Short-Term Operating Cash Flow Coverage |
0.40 |
| Operating Cash Flow Coverage |
0.02 |
| Capital Expenditure Coverage |
0.62 |
| Dividend + Capital Expenditure Coverage |
0.62 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
21.31 |
| EPS |
-6.729 |
| Debt/Share |
27.6138 |
| Cash/Share |
3.44 |
| Book Value/Share |
13.60 |
| Tangible BV/Share |
-9.20 |
| Equity/Share |
13.60 |
| Operating Cash Flow/Share |
0.656 |
| Capital Expenditure/Share |
1.061 |
| FCF/Share |
-0.405 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.917 |
| Earnings Before Tax/EBIT |
-8.248 |
| Price/Fair Value |
0.91 |
| Debt/Market Cap |
1.9471 |
| Effective Tax Rate |
8.3% |
| Enterprise Value Multiple |
-8.43 |
IART - Integra LifeSciences Holdings Corporation